Sui, a decentralized layer-1 blockchain touted as a "Solana killer," experienced a major outage on Nov. 21, halting block production for over an hour. Ironically, Sui went down while aiming to outshine Solana, a network notorious for its own downtime. $SUI
💡 Today we will talk about the CPI. CPI is a major indicator that measures the change in commodity prices in a country. This directly affects the crypto market.
📈 When the CPI value increases (inflation increases), crypto prices can go down. Also, when the CPI value goes down, crypto prices can go up.
📅 CPI data is released on the 13th of every month. Since the market is volatile these days, a trader has to pay special attention.
⚡️ Pro Tip: Don't forget to put stop-loss orders in your trades. Use reputable platforms like Trading View for accurate market data.
BTC Dominance is the percentage of Bitcoin compared to the total value (market capitalization) of the entire cryptocurrency market**.**
For example:
• If the total cryptocurrency market is valued at $1 trillion, • If the Bitcoin market cap is $500 billion, • BTC Dominance = (500 billion ÷ 1 trillion) × 100 = 50%.
Increasing BTC Dominance:
• High demand for Bitcoin. • It can be considered that investors trust Bitcoin more than other altcoins (Ethereum, Ripple, etc.).
Declining BTC Dominance:
• Investing more in Altcoins or choosing Altcoins instead of Bitcoin. • An opportunity for Altcoins to successfully earn more value.
Simply put, BTC Dominance is a measure of how much Bitcoin has in the crypto market.
JUST IN: Billionaire investor Paul Tudor Jones has increased his fund's #Bitcoin holdings by 5x to $159.9 million through BlackRock's ETF - SEC filings
Tia USDT offers a secure, fast, and decentralized solution for stablecoin transactions, ideal for users seeking efficiency and transparency in cryptocurrency operations.
JUST IN: 🇺🇸 RFK Jr. says "Bitcoin is the currency of freedom."
Bitcoin is "a hedge against inflation for middle class Americans, a remedy against the dollar's downgrade from the world's reserve currency, and the offramp from a ruinous national debt."
🔽AbbVie Shares Plummet After Failed Trial Of Drug To Treat Schizophrenia
The company fell 12% as two trials of the drug emraclidine failed to show statistically significant improvement on a scale used to measure the severity of mental illness symptoms